Publications by authors named "Franchesca D Choi"
Background: While alopecia areata (AA) has been associated with atopy, the immunological relationship is unclear, with the association of specific atopic and systemic respiratory diseases not established. The relationship between T-helper (Th)1-mediated AA and Th2-mediated atopy challenges the conventional Th1/Th2 paradigm of autoimmune disease categorization.
Objectives: To determine the association between AA and atopic respiratory diseases in adults and children, and respiratory diseases in general.
Background: Immunotherapy using programmed cell death 1 protein (PD-1) or programmed death-ligand 1 (PD-L1) inhibitors has been increasingly reported in a variety of nonmelanoma skin cancers (NMSCs).
Objective: To analyze the evidence of PD-1 and PD-L1 inhibitors in the treatment of NMSC.
Methods: A primary literature search was conducted with the PubMed, Cochrane Library, EMBASE, Web of Science, and CINAHL databases through October 28, 2018, to include studies on the use of PD-1 or PD-L1 inhibitors in patients for NMSC.
Introduction: Topical minoxidil is the first-line therapy for treating both male and female androgenetic alopecia. Currently there are no comprehensive reviews on the clinical efficacy of minoxidil on hair loss. Method: A literature search was conducted to identify clinically relevant studies regarding the efficacy of topical minoxidil for human subjects for hair loss.
View Article and Find Full Text PDFArticle Synopsis
- The use of collagen supplements for skincare is growing, but there are concerns about their quality and effectiveness due to lack of regulations.
- Recent clinical studies aim to evaluate the impact of these supplements on skin health, including anti-aging benefits.
- The findings suggest that collagen can improve skin elasticity and hydration, and it's generally safe, but more research is required to establish optimal dosages and effectiveness for specific skin conditions.
Although labeling changes and market withdrawal have been implemented for oral ketoconazole (KTZ) due to serious adverse effects (AEs), topical KTZ is generally thought to be effective and safe for the treatment of superficial fungal infections. New dermatologic indications for the use of topical KTZ have arisen such as onychomycosis, blepharitis, and hair loss. This article aims to review the literature on topical KTZ's efficacy and AEs, as well as provide an overview on current insights regarding its mechanism of action and upcoming developments.
View Article and Find Full Text PDF